Elizabeth K. Graydon , Allison M.W. Malloy , Kawthar Machmach , Peifang Sun , Dominic Paquin-Proulx , Stephen Lizewski , Rhonda Lizewski , Dawn L. Weir , Carl W. Goforth , Stephen K. Anderson , Andrew G. Letizia , Edward Mitre
{"title":"High baseline frequencies of natural killer cells are associated with asymptomatic SARS-CoV-2 infection","authors":"Elizabeth K. Graydon , Allison M.W. Malloy , Kawthar Machmach , Peifang Sun , Dominic Paquin-Proulx , Stephen Lizewski , Rhonda Lizewski , Dawn L. Weir , Carl W. Goforth , Stephen K. Anderson , Andrew G. Letizia , Edward Mitre","doi":"10.1016/j.crimmu.2023.100064","DOIUrl":null,"url":null,"abstract":"<div><p>This study tested the hypothesis that high frequencies of natural killer (NK) cells are protective against symptomatic SARS-CoV-2 infection. Samples were utilized from the COVID-19 Health Action Response for Marines study, a prospective, observational study of SARS-CoV-2 infection in which participants were enrolled prior to infection and then serially monitored for development of symptomatic or asymptomatic infection. Frequencies and phenotypes of NK cells (CD3<sup>−</sup>CD14<sup>−</sup>CD19<sup>−</sup>CD56<sup>+</sup>) were assessed by flow cytometry. Individuals that developed asymptomatic infections were found to have higher pre-infection frequencies of total NK cells compared to symptomatic individuals (10.61% [SD 4.5] vs 8.33% [SD 4.6], p = 0.011). Circulating total NK cells decreased over the course of infection, reaching a nadir at 4 weeks, while immature NK cells increased, a finding confirmed by multidimensional reduction analysis. These results indicate that NK cells likely play a key role in controlling the severity of clinical illness in individuals infected with SARS-CoV-2.</p></div>","PeriodicalId":72750,"journal":{"name":"Current research in immunology","volume":"4 ","pages":"Article 100064"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fb/51/main.PMC10461189.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current research in immunology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590255523000100","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Immunology and Microbiology","Score":null,"Total":0}
引用次数: 1
Abstract
This study tested the hypothesis that high frequencies of natural killer (NK) cells are protective against symptomatic SARS-CoV-2 infection. Samples were utilized from the COVID-19 Health Action Response for Marines study, a prospective, observational study of SARS-CoV-2 infection in which participants were enrolled prior to infection and then serially monitored for development of symptomatic or asymptomatic infection. Frequencies and phenotypes of NK cells (CD3−CD14−CD19−CD56+) were assessed by flow cytometry. Individuals that developed asymptomatic infections were found to have higher pre-infection frequencies of total NK cells compared to symptomatic individuals (10.61% [SD 4.5] vs 8.33% [SD 4.6], p = 0.011). Circulating total NK cells decreased over the course of infection, reaching a nadir at 4 weeks, while immature NK cells increased, a finding confirmed by multidimensional reduction analysis. These results indicate that NK cells likely play a key role in controlling the severity of clinical illness in individuals infected with SARS-CoV-2.